Arbutus Biopharma
ABUS
ABUS
55 hedge funds and large institutions have $212M invested in Arbutus Biopharma in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
39% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 18
52% less capital invested
Capital invested by funds: $442M → $212M (-$230M)
Holders
55
Holding in Top 10
1
Calls
$1.4M
Puts
$864K
Top Buyers
| 1 | +$4.62M | |
| 2 | +$2.59M | |
| 3 | +$2.56M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.42M |
| 5 |
Axa
Paris,
France
|
+$2.29M |
Top Sellers
| 1 | -$20.2M | |
| 2 | -$11.5M | |
| 3 | -$9.2M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$5.1M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
-$4.39M |